Menopause Cognitive and Mood Support Panel

Yes. Cognitive changes including difficulty concentrating, short-term memory lapses, word-finding difficulties, and general mental slowing are reported by a significant proportion of peri- and post-menopausal women. Research suggests that oestrogen supports cognitive function and neuroplasticity, and its decline contributes to these changes — particularly in the early post-menopausal years. The good news is that for most women, menopausal cognitive changes improve after the transition is complete and may be further supported by HRT. However, correctable co-contributors such as thyroid dysfunction, B12 deficiency, and anaemia must be excluded before attributing all cognitive symptoms to oestrogen loss.

The thyroid hormones T3 and T4 regulate metabolism throughout the body, including the brain. The brain has a particularly high density of thyroid hormone receptors, and even mildly suboptimal thyroid function can impair cognitive speed, memory consolidation, and mood. Hypothyroidism is 5 to 8 times more common in women than men and increases in prevalence after menopause — partly due to increasing autoimmune thyroid disease. Because hypothyroid symptoms overlap significantly with menopausal symptoms (fatigue, cold intolerance, weight gain, mood changes, cognitive slowing), TSH testing is an essential first step in evaluating post-menopausal cognitive complaints.

Total B12 measures all circulating cobalamin, including inactive forms bound to proteins that cells cannot access. Active B12 (holotranscobalamin) measures only the fraction bound to transcobalamin II — the fraction that tissues can actually take up and use. Research shows that active B12 is a more sensitive early indicator of functional deficiency. Some individuals have normal total B12 but low active B12, meaning their cells are functionally B12-deficient despite apparently adequate blood levels. This is particularly relevant for older post-menopausal women, who commonly have impaired B12 absorption, and those on PPIs or metformin.

Yes. Iron is required for the synthesis of dopamine, serotonin, and norepinephrine — neurotransmitters that regulate mood, motivation, and cognitive function. Low ferritin (even within the ‘normal’ range) is associated with reduced cognitive performance, poor concentration, and mood disturbances. Because post-menopausal women are no longer losing iron through menstruation, frank iron deficiency is less common than in premenopausal women — but it can still occur through dietary insufficiency, poor absorption, or gastrointestinal blood loss. If ferritin is low, investigating the cause is important regardless of whether the haemoglobin is normal.

Vitamin D acts as a neurosteroid and has receptors throughout the brain, including in regions involved in mood regulation and memory. Multiple epidemiological studies link vitamin D deficiency to higher rates of depression, anxiety, and cognitive decline. While the evidence for supplementation directly improving mood is mixed, correcting deficiency in women who are genuinely deficient appears to have meaningful benefits for energy, mood, and cognitive clarity. Given that deficiency is extremely common in UK post-menopausal women — particularly in winter or in women who cover their skin or rarely go outdoors — it is a simple and important target to address.

Your physician report will outline any out-of-range values and provide clear recommendations. For thyroid dysfunction, your GP can arrange further testing and treatment if required. For B12 deficiency, supplementation (typically oral high-dose B12 or injections in severe cases) is highly effective. For ferritin deficiency, iron supplementation under medical guidance — with monitoring to confirm response — is appropriate. For vitamin D deficiency, supplementation dosing will be recommended based on your level. Retesting 3 to 4 months after commencing supplementation is advisable to confirm effective response and dose adequacy.